CUTANEOUS B-CELL LYMPHOMA

This adverse event was reported 61 times

CUTANEOUS B-CELL LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DUVELISIB 2 0.0023
1 ETOPOSIDE PHOSPHATE 2 0.0012
2 FINGOLIMOD HYDROCHLORIDE 3 0.0006
3 ADALIMUMAB-FKJP 17 0.0004
4 ADALIMUMAB-AATY 17 0.0003
5 ADALIMUMAB-ADAZ 17 0.0003
6 MYCOPHENILIC ACID 5 0.0002
7 MYCOPHENOLIC ACID 5 0.0002
8 DOXORUBICIN 13 0.0001
9 METHYLPREDNISOLONE ACETATE 1 0.0001
See all drugs enriched for association with CUTANEOUS B-CELL LYMPHOMA